MONOPTEROS

Serial Number 87827412
Registration 6754547
700

Registration Progress

Application Filed
Mar 9, 2018
Under Examination
Apr 23, 2019
Approved for Publication
Feb 26, 2019
Published for Opposition
Feb 26, 2019
Registered
Jun 7, 2022

Trademark Image

MONOPTEROS

Basic Information

Serial Number
87827412
Registration Number
6754547
Filing Date
March 9, 2018
Registration Date
June 7, 2022
Published for Opposition
February 26, 2019
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 7, 2022
Registration
Registered
Classes
005

Rights Holder

Monopteros Therapeutics, Inc.

03
Address
78 Randolph Road
Chestnut Hill, MA 02467

Ownership History

Monopteros Therapeutics, Inc.

Original Applicant
03
Chestnut Hill, MA

Monopteros Therapeutics, Inc.

Owner at Publication
03
Chestnut Hill, MA

Monopteros Therapeutics, Inc.

Original Registrant
03
Chestnut Hill, MA

Legal Representation

Attorney
Jenevieve Maerker, Esq.

USPTO Deadlines

Next Deadline
1052 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-06-07)
Due Date
June 07, 2028
Grace Period Ends
December 07, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

43 events
Date Code Type Description Documents
Jun 7, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 7, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 5, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 4, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 3, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 25, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 25, 2022 IUAF S USE AMENDMENT FILED Loading...
Oct 20, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 19, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 18, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 12, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 14, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 12, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 12, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 13, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 9, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 9, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 9, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 18, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 16, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 16, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 16, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 25, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 23, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 23, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 23, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 23, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 26, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 26, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 6, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 17, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 4, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 4, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 31, 2018 ALIE A ASSIGNED TO LIE Loading...
Dec 24, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 22, 2018 CPRA R PRIORITY ACTION WRITTEN Loading...
Jun 22, 2018 GPRA F PRIORITY ACTION E-MAILED Loading...
Jun 22, 2018 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Jun 21, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 15, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 13, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for human use for treatment of oncological diseases and/or disorders; house mark for pharmaceutical preparations, namely, pharmaceuticals for treatment of oncological diseases and/or disorders
First Use Anywhere: 20210400
First Use in Commerce: 20210400

Classification

International Classes
005